Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonDividends Paid - PreferredFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Gains from Investment Securities: 2010-2025

Historic Gains from Investment Securities for Amdocs (DOX) over the last 16 years, with Sep 2025 value amounting to $901,000.

  • Amdocs' Gains from Investment Securities fell 59.70% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.4 million, marking a year-over-year decrease of 34.72%. This contributed to the annual value of $901,000 for FY2025, which is 22.26% down from last year.
  • As of FY2025, Amdocs' Gains from Investment Securities stood at $901,000, which was down 22.26% from $1.2 million recorded in FY2024.
  • In the past 5 years, Amdocs' Gains from Investment Securities ranged from a high of $146.4 million in FY2021 and a low of $901,000 during FY2025.
  • Moreover, its 3-year median value for Gains from Investment Securities was $1.2 million (2024), whereas its average is $1.2 million.
  • In the last 5 years, Amdocs' Gains from Investment Securities spiked by 222.57% in 2021 and then plummeted by 98.33% in 2022.
  • Over the past 5 years, Amdocs' Gains from Investment Securities (Yearly) stood at $146.4 million in 2021, then crashed by 98.33% to $2.4 million in 2022, then slumped by 34.58% to $1.6 million in 2023, then declined by 27.43% to $1.2 million in 2024, then decreased by 22.26% to $901,000 in 2025.